176 related articles for article (PubMed ID: 33399076)
1. The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center.
Quero G; Salvatore L; Fiorillo C; Bagalà C; Menghi R; Maria B; Cina C; Laterza V; Di Stefano B; Maratta MG; Ribelli M; Galiandro F; Mattiucci GC; Brizi MG; Genco E; D'Aversa F; Zileri L; Attili F; Larghi A; Perri V; Inzani F; Gasbarrini A; Valentini V; Costamagna G; Manfredi R; Tortora G; Alfieri S
ESMO Open; 2021 Feb; 6(1):100010. PubMed ID: 33399076
[TBL] [Abstract][Full Text] [Related]
2. The role of the multidisciplinary tumor board (MDTB) in the assessment of pancreatic cancer diagnosis and resectability: A tertiary referral center experience.
Quero G; De Sio D; Fiorillo C; Menghi R; Rosa F; Massimiani G; Laterza V; Lucinato C; Galiandro F; Papa V; Salvatore L; Bensi M; Tortorelli AP; Tondolo V; Alfieri S
Front Surg; 2023; 10():1119557. PubMed ID: 36874464
[TBL] [Abstract][Full Text] [Related]
3. Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study.
Brauer DG; Strand MS; Sanford DE; Kushnir VM; Lim KH; Mullady DK; Tan BR; Wang-Gillam A; Morton AE; Ruzinova MB; Parikh PJ; Narra VR; Fowler KJ; Doyle MB; Chapman WC; Strasberg SS; Hawkins WG; Fields RC
HPB (Oxford); 2017 Feb; 19(2):133-139. PubMed ID: 27916436
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer.
Valerio MR; Serretta V; Arico D; Fazio I; Altieri V; Baldari S; Pennisi M; Girlando A; Spada M; Gesolfo CS; Messina M; Messina C; Giorgia L; Sortino G; DI Grazia A; Guggino R; Borsellino N; Piazza D; Gebbia V
Anticancer Res; 2023 Jan; 43(1):501-508. PubMed ID: 36585190
[TBL] [Abstract][Full Text] [Related]
5. Match between therapeutic proposal in multidisciplinary tumor board and actual treatment in head and neck cancer.
Alkasbi J; Mortuaire G; Rysman B; Nicot R; Chevalier D; Mouawad F
Eur Ann Otorhinolaryngol Head Neck Dis; 2021 Sep; 138(4):247-252. PubMed ID: 33257266
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period.
Savino G; Piccinni F; Pagliara MM; Sammarco MG; Caputo CG; Moro A; Barbera G; Tagliaferri L; Fionda B; Schinzari G; Rossi E; Zagaria L; Peris K; Di Stefani A; Musarra T; Ausili Cefaro L; Martucci M; Blasi MA
BMC Ophthalmol; 2022 Dec; 22(1):497. PubMed ID: 36536312
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary Management of Hepatocellular Carcinoma Improves Access to Therapy and Patient Survival.
Agarwal PD; Phillips P; Hillman L; Lucey MR; Lee F; Mezrich JD; Said A
J Clin Gastroenterol; 2017 Oct; 51(9):845-849. PubMed ID: 28877082
[TBL] [Abstract][Full Text] [Related]
8. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
9. Subspecialized radiology review at multidisciplinary pancreas conference: impact on patient management.
Chingkoe CM; Brook A; Moser AJ; Mortele KJ
Abdom Radiol (NY); 2018 Oct; 43(10):2783-2789. PubMed ID: 29550957
[TBL] [Abstract][Full Text] [Related]
10. The impact of a multidisciplinary team approach on the management of focal pancreatic lesions: a single tertiary center experience.
Francisse S; Gkolfakis P; Viesca MFY; Mans L; Demols A; Pezzullo M; Loi P; Navez J; Closset J; Bali MA; Wettere MV; D'Haene N; Demetter P; Verset L; Bouchart C; Lemmers A; Deviere J; Delhaye M; Laethem JV; Arvanitakis M
Ann Gastroenterol; 2023; 36(5):580-587. PubMed ID: 37664233
[TBL] [Abstract][Full Text] [Related]
11. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.
Wittel UA; Lubgan D; Ghadimi M; Belyaev O; Uhl W; Bechstein WO; Grützmann R; Hohenberger WM; Schmid A; Jacobasch L; Croner RS; Reinacher-Schick A; Hopt UT; Pirkl A; Oettle H; Fietkau R; Golcher H
BMC Cancer; 2019 Oct; 19(1):979. PubMed ID: 31640628
[TBL] [Abstract][Full Text] [Related]
12. Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer.
Kim YE; Park MS; Hong HS; Kang CM; Choi JY; Lim JS; Lee WJ; Kim MJ; Kim KW
Radiology; 2009 Mar; 250(3):758-65. PubMed ID: 19164113
[TBL] [Abstract][Full Text] [Related]
13. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography.
Soriano A; Castells A; Ayuso C; Ayuso JR; de Caralt MT; Ginès MA; Real MI; Gilabert R; Quintó L; Trilla A; Feu F; Montanyà X; Fernández-Cruz L; Navarro S
Am J Gastroenterol; 2004 Mar; 99(3):492-501. PubMed ID: 15056091
[TBL] [Abstract][Full Text] [Related]
14. Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement.
Joo I; Lee JM; Lee ES; Son JY; Lee DH; Ahn SJ; Chang W; Lee SM; Kang HJ; Yang HK
Radiology; 2019 Nov; 293(2):343-349. PubMed ID: 31502935
[TBL] [Abstract][Full Text] [Related]
15. Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study.
Heinrich S; Besselink M; Moehler M; van Laethem JL; Ducreux M; Grimminger P; Mittler J; Lang H; Lutz MP; Lesurtel M;
BMC Cancer; 2019 Jul; 19(1):675. PubMed ID: 31288786
[TBL] [Abstract][Full Text] [Related]
16. Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation.
Kirkegård J; Aahlin EK; Al-Saiddi M; Bratlie SO; Coolsen M; de Haas RJ; den Dulk M; Fristrup C; Harrison EM; Mortensen MB; Nijkamp MW; Persson J; Søreide JA; Wigmore SJ; Wik T; Mortensen FV
Br J Surg; 2019 May; 106(6):756-764. PubMed ID: 30830974
[TBL] [Abstract][Full Text] [Related]
17. [Resectability of pancreatic cancer: New criteria].
D'Haese JG; Werner J
Radiologe; 2016 Apr; 56(4):318-24. PubMed ID: 26993121
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
[TBL] [Abstract][Full Text] [Related]
19. Preoperative MDCT Assessment of Resectability in Borderline Resectable Pancreatic Cancer: Effect of Neoadjuvant Chemoradiation Therapy.
Joo I; Lee JM; Lee ES; Ahn SJ; Lee DH; Kim SW; Ryu JK; Oh DY; Kim K; Lee KB; Jang JY
AJR Am J Roentgenol; 2018 May; 210(5):1059-1065. PubMed ID: 29489408
[TBL] [Abstract][Full Text] [Related]
20. Clinical questions on rehabilitation in cancer patients with skeletal metastasis: a content analysis of the multidisciplinary tumor board records.
Yamanaka N; Tsukamoto S; Ishida Y; Shigematsu H; Hasegawa M; Sajiki M; Mano T; Tanaka Y; Kido A
Support Care Cancer; 2021 Apr; 29(4):2015-2020. PubMed ID: 32844315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
